Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

7,048 results
MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 3
1967 3
1968 2
1969 4
1970 3
1971 2
1972 5
1973 3
1974 4
1975 2
1976 5
1977 8
1978 6
1979 17
1980 11
1981 10
1982 23
1983 34
1984 29
1985 45
1986 47
1987 50
1988 59
1989 59
1990 70
1991 57
1992 85
1993 62
1994 90
1995 91
1996 87
1997 62
1998 86
1999 87
2000 82
2001 105
2002 129
2003 149
2004 187
2005 190
2006 198
2007 221
2008 288
2009 325
2010 368
2011 337
2012 456
2013 515
2014 592
2015 738
2016 616
2017 530
2018 602
2019 216
Text availability
Article attribute
Article type
Publication date

Search Results

7,048 results
Results by year
Filters applied: . Clear all
Page 1
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
Gluz O, et al. J Clin Oncol 2016 - Clinical Trial. PMID 26926676
PURPOSE: The 21-gene Recurrence Score (RS) assay is a validated prognostic/predictive tool in early hormone receptor-positive breast cancer (BC); however, only a few prospective outcome results have been available so far. ...Nodal status, central and local grade, the Ki-67 protein encoded by the MKI67 gene, estrogen receptor, progesterone receptor, tumor size, and RS were univariate prognostic factors for disease-free survival; only nodal status, both central and local grade, and RS were independent multivariate factors. ...
PURPOSE: The 21-gene Recurrence Score (RS) assay is a validated prognostic/predictive tool in early hormone receptor-positive breast cancer (BC); however, only a few prospective outcome results have been available so far. ...Nodal status, central and local grade, the Ki-67 protein enco …
Targeting Cancer Cell Dormancy
Recasens A and Munoz L. Trends Pharmacol Sci 2019 - Review. PMID 30612715
Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
Osterman E and Glimelius B. Dis Colon Rectum 2018. PMID 30086050
OBJECTIVE: To investigate the recurrence rate in a large population-based cohort after modern staging, surgery, and pathology have been implemented. ...CONCLUSIONS: The recurrence rate is less than that previously observed in historical materials, but current, commonly used risk factors are still useful in evaluating recurrence risks. ...
OBJECTIVE: To investigate the recurrence rate in a large population-based cohort after modern staging, surgery, and pathology have been implemented. ...CONCLUSIONS: The recurrence rate is less than that previously observed in historical materials, but current, commonly used risk …
Cancer of the corpus uteri
Amant F, et al. Int J Gynaecol Obstet 2018. PMID 30306580
Recurrence needs to be prevented since the prognosis for recurrent endometrial cancer is dismal. Treatment tailored to tumor biology is the optimal strategy to balance treatment efficacy against toxicity. ...
Recurrence needs to be prevented since the prognosis for recurrent endometrial cancer is dismal. Treatment tailored to tumor biology is the optimal strategy to balance treatment efficacy against toxicity. ...
Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis.
Lu Y, et al. Ann Surg Oncol 2019. PMID 30617873
BACKGROUND: This systematic review and meta-analysis aimed to investigate local recurrence (LR) rates among the three grades (benign, borderline, and malignant) of phyllodes tumors (PTs). ...
BACKGROUND: This systematic review and meta-analysis aimed to investigate local recurrence (LR) rates among the three grades (benign, borderline, and malignant) of phyllodes tumors (PTs). ...
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis
Broglio KR, et al. JAMA Oncol 2016. PMID 26914222
CONCLUSIONS AND RELEVANCE: Pathologic complete response in HER2-positive breast cancer is associated with substantially longer times to recurrence and death. ...
CONCLUSIONS AND RELEVANCE: Pathologic complete response in HER2-positive breast cancer is associated with substantially longer times to recurrence and death. ...
High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival.
Willeumier J, et al. Int Orthop 2015. PMID 25743028
Tumour size proved a consistent adverse prognostic factor for local recurrence (hazard ratio (HR) 3.9), distant metastasis (HR 4.9) and overall survival (HR 2.4). ...The occurrence of local recurrence had a significant impact on overall survival (HR 2.0). CONCLUSIONS: The results of this study confirm the critical role of tumour size on survival and margins on local recurrence, and stress the need for further investigation concerning the association between margins, local recurrence and survival....
Tumour size proved a consistent adverse prognostic factor for local recurrence (hazard ratio (HR) 3.9), distant metastasis (HR 4.9) and overall survival (HR 2.4). ...The occurrence of local recurrence had a significant impact on overall survival (HR 2.0). CONCLUSIONS: The …
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST).
Voogd AC, et al. Eur J Cancer 1999 - Clinical Trial. PMID 10673999
The purpose of this study was to determine which histological factors are associated with an increased risk for local recurrence in the breast after breast-conserving therapy for early breast cancer (TNM stage I and II) and whether risk patterns vary according to menopausal status and type of local recurrence. ...To prevent local recurrence at or near the site of the primary tumour, local excision with a 1-2 cm margin of healthy tissue and a 15 Gy boost seemed adequate local treatment for patients with well differentiated EIC. ...
The purpose of this study was to determine which histological factors are associated with an increased risk for local recurrence in the breast after breast-conserving therapy for early breast cancer (TNM stage I and II) and whether risk patterns vary according to menopausal status and …
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
Pucar D, et al. Int J Radiat Oncol Biol Phys 2007. PMID 17707266
The ratios between tumor volumes on pathology and on post-RT MRI ranged from 0.52 to 2.80. CONCLUSIONS: Our study provides a direct visual confirmation that clinically significant post-RT local recurrence occurs at the site of primary tumor. ...They also suggest that monitoring of primary tumor with pre-RT and post-RT MRI could lead to early detection of local recurrence amenable to salvage treatment....
The ratios between tumor volumes on pathology and on post-RT MRI ranged from 0.52 to 2.80. CONCLUSIONS: Our study provides a direct visual confirmation that clinically significant post-RT local recurrence occurs at the site of primary tumor. ...They also suggest that monitoring …
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.
Fossati N, et al. Eur Urol 2019 - Clinical Trial. PMID 30301694
BACKGROUND: Salvage lymph node dissection (SLND) represents a possible treatment option for prostate cancer patients affected by nodal recurrence after local treatment. ...OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The study outcome was early clinical recurrence (eCR) developed within 1 yr after SLND. ...
BACKGROUND: Salvage lymph node dissection (SLND) represents a possible treatment option for prostate cancer patients affected by nodal recurrence after local treatment. ...OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The study outcome was early clinical recurrence (eCR) develo …
7,048 results
Jump to page
Feedback